Leflunomide is an isoxazole immunomodulatory agent that inhibits dihydroorotate dehydrogenase and has antiproliferative activity. Several in vivo and in vitro experimental models have demonstrated an anti-inflammatory effect
Pharmaceutical Class: Disease-Modifying Antirheumatic Drug (DMARD)
Dosage Form and Strength: Film coated tablet (10, 20 mg)
Product Description:
Indications:
Treatment of active rheumatoid arthritis in adults
Lerava® is the first generic form of Leflunomide in Iran which is produced at a GMP approved manufacturing site